{"id":"https://openalex.org/W4397042353","doi":"https://doi.org/10.1681/asn.20233411s1391c","title":"Disease Progression in Patients with Two APOL1 Variants and Proteinuric CKD from the AASK, CRIC, and FSGS-CT Datasets","display_name":"Disease Progression in Patients with Two APOL1 Variants and Proteinuric CKD from the AASK, CRIC, and FSGS-CT Datasets","publication_year":2023,"publication_date":"2023-11-01","ids":{"openalex":"https://openalex.org/W4397042353","doi":"https://doi.org/10.1681/asn.20233411s1391c"},"language":"en","primary_location":{"id":"doi:10.1681/asn.20233411s1391c","doi":"https://doi.org/10.1681/asn.20233411s1391c","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20233411s1391c","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111960793","display_name":"Michael S. Lipkowitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799903593","display_name":"Georgetown University Medical Center","ror":"https://ror.org/00hjz7x27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799903593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Lipkowitz","raw_affiliation_strings":["Georgetown University Medical Center, Washington, DC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown University Medical Center, Washington, DC;","institution_ids":["https://openalex.org/I2799903593"]}]},{"author_position":"middle","author":{"id":null,"display_name":"George Manos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Manos","raw_affiliation_strings":["Vertex Pharmaceuticals Incorporated, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharmaceuticals Incorporated, Boston, MA;","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060991592","display_name":"Prasad L. Gawade","orcid":"https://orcid.org/0000-0002-3396-5349","observed_orcids":["https://orcid.org/0000-0002-3396-5349"]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Prasad L. Gawade","raw_affiliation_strings":["Vertex Pharmaceuticals Incorporated, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharmaceuticals Incorporated, Boston, MA;","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081122182","display_name":"Will Eagan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Will A. Eagan","raw_affiliation_strings":["Vertex Pharmaceuticals Incorporated, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharmaceuticals Incorporated, Boston, MA;","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100706245","display_name":"Yang Yuan","orcid":"https://orcid.org/0000-0002-5552-4958","observed_orcids":["https://orcid.org/0000-0002-5552-4958"]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuan Yang","raw_affiliation_strings":["Vertex Pharmaceuticals Incorporated, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharmaceuticals Incorporated, Boston, MA;","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089580323","display_name":"Ogo I. Egbuna","orcid":"https://orcid.org/0000-0003-0548-3809","observed_orcids":["https://orcid.org/0000-0003-0548-3809","https://orcid.org/0009-0009-5996-3147"]},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ogo I. Egbuna","raw_affiliation_strings":["Vertex Pharmaceuticals Incorporated, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vertex Pharmaceuticals Incorporated, Boston, MA;","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034939991","display_name":"Glenn Matthew Chertow","orcid":"https://orcid.org/0000-0002-7599-0534","observed_orcids":["https://orcid.org/0000-0002-7599-0534"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Glenn Chertow","raw_affiliation_strings":["Stanford University School of Medicine, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University School of Medicine, Palo Alto, CA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.31965007,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"11S","first_page":"391","last_page":"392"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.042399998754262924,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/apol1-variants","display_name":"APOL1 variants","score":0.9089999794960022},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.9160000085830688},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate-decline","display_name":"estimated glomerular filtration rate decline","score":0.9139999747276306},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.9739999771118164},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.6389999985694885},{"id":"https://openalex.org/keywords/glomerular-disease","display_name":"glomerular disease","score":0.6370000243186951},{"id":"https://openalex.org/keywords/african-american-patients","display_name":"African American patients","score":0.5009999871253967}],"concepts":[{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.6162621974945068},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.6098203063011169},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5161327123641968},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.43576130270957947},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3812991976737976},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3363308608531952}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.20233411s1391c","doi":"https://doi.org/10.1681/asn.20233411s1391c","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20233411s1391c","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4417186283","https://openalex.org/W4397042890","https://openalex.org/W4403833096","https://openalex.org/W4396989965","https://openalex.org/W4380625611","https://openalex.org/W2002359955","https://openalex.org/W2765552784","https://openalex.org/W2138846140","https://openalex.org/W7163877739","https://openalex.org/W7104536816"],"abstract_inverted_index":{"Background:":[0],"Two":[1],"variants":[2,28,45],"in":[3,23,50,78,93,151,191,236,239],"Apolipoprotein":[4],"L1":[5],"(APOL1)":[6],"lead":[7],"to":[8,15,85,126,131,139,178,211,220,244],"proteinuric":[9,30,47],"chronic":[10],"kidney":[11,18,133,237],"disease":[12,19,134],"(CKD)":[13],"referred":[14],"as":[16,124],"APOL1-mediated":[17],"(AMKD).":[20],"Disease":[21,57],"progression":[22],"persons":[24],"with":[25,42,82,95,241],"two":[26,43,180],"APOL1":[27,44,181],"and":[29,46,58,67,80,91,103,136,171,184,194,199,216,248,259],"CKD":[31,48],"is":[32],"not":[33],"well-understood.":[34],"Methods:":[35],"We":[36],"analyzed":[37],"data":[38,115],"from":[39,149,165,169,174],"non-diabetic":[40],"patients":[41,164,168,173,206,240],"enrolled":[49],"the":[51,153,231,251,257],"African":[52],"American":[53],"Study":[54],"of":[55,147,155,162,213,224,234,253,261],"Kidney":[56],"Hypertension":[59],"(AASK),":[60],"Chronic":[61],"Renal":[62],"Insufficiency":[63],"Cohort":[64],"(CRIC)":[65],"study,":[66],"Focal":[68],"Segmental":[69],"Glomerulosclerosis":[70],"Clinical":[71],"Trial":[72],"(FSGS-CT).":[73],"The":[74,186],"analysis":[75],"included":[76],"participants":[77,92],"AASK":[79],"CRIC":[81],"urine":[83],"protein":[84],"creatinine":[86],"ratio":[87],"(UPCR)":[88],"\u22650.7":[89],"g/g":[90],"FSGS-CT":[94,175,195],"UPCR":[96],"\u22651.0":[97],"g/g.":[98],"Baseline":[99],"age,":[100],"sex,":[101],"UPCR,":[102],"estimated":[104,187],"glomerular":[105,246],"filtration":[106],"rate":[107,233],"(eGFR)":[108],"were":[109,176],"determined":[110],"at":[111],"enrollment.":[112],"For":[113],"each":[114],"set,":[116],"we":[117],"derived":[118],"an":[119],"annual":[120,188],"eGFR":[121,189],"slope":[122,190],"estimate":[123],"related":[125],"persistent":[127],"proteinuria,":[128],"median":[129,137,209,218],"time":[130,138,210,219],"end-stage":[132],"(ESKD),":[135],"composite":[140,221],"clinical":[141,222,254],"outcome":[142,223],"based":[143],"on":[144],"a":[145,208,217],"decline":[146,235],"\u226530%":[148],"baseline":[150],"eGFR,":[152],"onset":[154],"ESKD,":[156],"or":[157],"death.":[158],"Results:":[159],"A":[160],"total":[161],"38":[163],"AASK,":[166,192],"47":[167],"CRIC,":[170,193],"27":[172],"found":[177],"have":[179],"variants,":[182],"CKD,":[183],"proteinuria.":[185],"was":[196],"-5.80,":[197],"-8.55,":[198],"-19.08":[200],"mL/min/1.73m2/year,":[201],"respectively.":[202],"Across":[203],"all":[204],"studies,":[205],"had":[207],"ESKD":[212],"<4":[214],"years":[215],"\u22642.14":[225],"years.":[226],"Conclusions:":[227],"These":[228],"results":[229],"highlight":[230],"rapid":[232],"function":[238],"AMKD":[242],"relative":[243],"other":[245],"diseases":[247],"may":[249],"inform":[250],"design":[252],"trials":[255],"testing":[256],"safety":[258],"efficacy":[260],"APOL1-targeted":[262],"therapies.":[263],"Funding:":[264],"NIDDK":[265],"Support,":[266],"Commercial":[267],"Support":[268],"-":[269],"Vertex":[270],"Pharmaceuticals":[271],"Incorporated":[272]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2024-05-19T00:00:00"}